Get started
Amgen Inc.Amgen Inc.Amgen Inc.

Amgen Inc.

No trades
OverviewFinancialsNewsDocumentsIdeasMindsTechnicalsForecastsSeasonalsOptionsBondsETFs

Market insights

Amgen’s Ascending TriangleAmgen rallied sharply last month, and some traders may see more upside in the drug maker. The first pattern on today’s chart is the advance after earnings and revenue beat estimates on November 4. Such a move may reflect improved sentiment. Second is the $337.38 level, AMGN’s previous record-high closing price from 2024. The shares have remained near (and often above) that level for more than three weeks. Is a breakout next? Third is the series of higher lows as prices challenge resistance. That ascending triangle is a potentially bullish continuation pattern. Next, the 8-day exponential moving average (EMA) has remained above the 21-day EMA. The 50-day simple moving average (SMA) also had a “golden cross” above the 200-day SMA last month. Those signals may suggest short- and long-term directions have gotten more positive. TradeStation has, for decades, advanced the trading industry, providing access to stocks, options and futures. If you're born to trade, we could be for you. See our Overview for more. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options or futures); therefore, you should not invest or risk money that you cannot afford to lose. Online trading is not suitable for all investors. View the document titled Characteristics and Risks of Standardized Options at www.TradeStation.com . Before trading any asset class, customers must read the relevant risk disclosure statements on www.TradeStation.com . System access and trade placement and execution may be delayed or fail due to market volatility and volume, quote delays, system and software errors, Internet traffic, outages and other factors. Securities and futures trading is offered to self-directed customers by TradeStation Securities, Inc., a broker-dealer registered with the Securities and Exchange Commission and a futures commission merchant licensed with the Commodity Futures Trading Commission). TradeStation Securities is a member of the Financial Industry Regulatory Authority, the National Futures Association, and a number of exchanges. TradeStation Securities, Inc. and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., both operating, and providing products and services, under the TradeStation brand and trademark. When applying for, or purchasing, accounts, subscriptions, products and services, it is important that you know which company you will be dealing with. Visit www.TradeStation.com for further important information explaining what this means.
NASDAQ:AMGN
by TradeStation
AMGN - Combo bullish signs======= Volume ======= - Healthy ========== Price Action ========== - Bullish flag spotted - Supported above $310 - Gapped up from a near 6 month ascending triangle ================= Technical Indicators ================= - Ichimoku >>> price above cloud >>> Green kumo expanding >>> Tenken - Above clouds, crossed Lagging & pointing up >>> Kijun - Above clouds, crossed Lagging & pointing up >>> Chiku - Above clouds, Conv, Base & pointing up slightly ========= Oscillators ========= >>> MACD - bullish >>> DMI - bullish >>> StochRSI - bullish, around overbought region ========= Conclusion ========= >>> Ichimoku overall - bullish >>> Oscillators overall - remains bullish >>> Additional comments - bullish trend remains intact with weak selling pressure withing the bull flag ========= Trade Plan ========= - short to long term breakout swing - price may reverse at current level, to enter spot or wait for pullback at entry 2. - Entries and exits depends on your time horizon and risk management. ========= Positions ========= Entry 1 - $324 Entry 2 - $310 Stop - $293 Exit 1 - $334 Exit 2 - $343 Exit 3 - $353 Exit 4 - $380 Exit 5 - $410
NASDAQ:AMGNLong
by Creedxx
AMGN on the Verge of a Major Breakout1. Technical Analysis AMGN has formed a bullish pennant pattern after a strong upside rally. This compression typically acts as a continuation setup, suggesting that buyers are preparing for another push higher—if the major resistance gives way. Key Resistance • $346.7 → Major multi-year resistance Bullish Scenario If AMGN breaks above 346.7: • Target 1: $360 • Target 2: $370 • Target 3: $385 Bullish catalysts: • Strong prior momentum • Bullish Pennant continuation pattern • Trading well above the 50-day SMA Bearish Scenario If price breaks below the pennant support: • Support 1: $330 • Support 2: $318 • Support 3: 50-day SMA (~$308) Suggested Stop-Loss For short-term traders: • Stop-Loss: A confirmed break below $330 (A close below 330 indicates weakness and invalidation of the pennant.) For swing/mid-term traders: • Stop-Loss (safer): $318 (Losing this level breaks the broader bullish structure.) 2. Fundamental Snapshot Positives • Strong revenue performance in specialty therapeutics • Recent earnings beat expectations • Healthy cash flow and margins • Expanding R&D pipeline and new partnerships Risks • Intense competition within biotech • Price-pressure risks • Regulatory and FDA-related uncertainties Summary: The fundamentals remain strong and support the bullish technical structure unless major negative catalysts emerge. 3. Final Summary AMGN is sitting at a critical inflection point. A breakout above 346.7 could trigger a new bullish leg, while weakness below 330 activates the stop-loss for short-term traders.
NASDAQ:AMGNLong
by isahebdadi
AMGN: the medicine cabinet for your portfolioOn the weekly chart, Amgen (AMGN) trades at $289.56, holding above the key $272–280 support zone, aligned with the 0.705–0.79 Fibo levels. This area forms a clear buy zone, where buyers are likely to step in. The technical structure remains bullish: the uptrend is intact, with targets at $346.85, matching historical highs and the upper boundary of the formation. Price currently sits near the lower part of the range, where volume accumulation could fuel the next upward move. Fundamentally , Amgen stands as a biotech heavyweight: its drug portfolio remains strong, late-stage pipeline candidates progress steadily, and recent earnings showed stable revenue and profit growth. Investors treat the stock as a defensive asset amid market volatility, with biotechnology demand remaining largely cycle-independent. Additionally, institutional funds have been accumulating positions, providing further support. Tactically , the $272–280 zone is critical: holding it preserves the bullish scenario. Should the bounce continue, the targets shift to $300 and $346.85. While a retest of support is possible, the broader structure remains upward. Amgen stays true to its name - when the market is sick, this stock has the cure.
NASDAQ:AMGNLong
by TotoshkaTrades
AMGN - To see a new high======= Volume ======= - neutral ========== Price Action ========== - rounding bottom recently - Ascending triangle noticed ================= Technical Indicators ================= - Ichimoku >>> price above cloud >>> Green kumo budding >>> Tenken - above clouds and pointing up >>> Chiku - within clouds and pointing up slightly >>> Kijun - Above clouds and pointing up ========= Oscillators ========= - MACD still bullish - DMI neutral - StochRSI, still bullish ========= Conclusion ========= - short to long term breakout swing - price may reverse at current level, to enter spot or wait for pullback at entry 2. ========= Positions ========= Entry - $298 Entry 2 - $286 Stop - $268 Exit 1 - $315 Exit 2 - $354 Exit 3 - $385 Exit 4 - $419 Exit 5 - $470
NASDAQ:AMGNLong
by Creedxx
Professional Technical Analysis of AMGN (Amgen Inc.) Looking at the daily chart of AMGN, here’s the outlook: 📊 Short-Term Outlook (1–4 weeks) Price Structure: The stock is testing a long-term ascending trendline (blue line). This level has repeatedly acted as strong support since early 2023. Risk: If buyers fail to defend the trendline, a breakdown could trigger further downside momentum. Key Support: $270 (trendline + psychological level). Short-Term Stop Loss: Below $265 on a confirmed daily close. Short-Term Target: If support holds, a rebound toward $290–300 is likely. ➡️ As long as price stays above $270, the short-term bias favors a bounce. 📊 Long-Term Outlook (2–6 months) Primary Trend: Long-term uptrend is intact, supported by the ascending trendline since 2022. Major Support Zone: $265–260 (if broken, the structure weakens significantly). Long-Term Stop Loss: Below $260 (confirmed close). Long-Term Targets: First target: $310 (previous swing highs). Next target: $330–335 if momentum continues. ➡️ Long-term bullish as long as AMGN respects the $260 support area. 🎯 Summary Short-Term Trade Idea: Buy near $270 support with a target of $290–300, stop loss at $265. Long-Term Position: Hold above $260 with upside targets at $310 and $330–335.
NASDAQ:AMGNLong
by isahebdadi
Utilizing algorithms to identify A+ trade opportunitiesMy typical video consists of analyzing a specific chart and telling its story. But here, I take a different approach and analyze how to actually capitalize on the knowledge we have through the algorithms. As you'll see, these are repeated algorithms that we've identified from previous price action - and as you'll see, they repeat beautifully, over and over again, on every chart. Let's test this theory and see if we can prove an above-average/high-probability trading setup through our tapered proof and subsequent rejection. We'll check back in on AMGN to see how this plays out and to what extent of profit this setup offers us! Happy Trading :)
NASDAQ:AMGN
by ReigningTrades
Pioneering Human Therapeutics $AMGNAmgen, Inc. is a biotechnology company that specializes in the discovery, development, manufacture, and marketing of human therapeutics. Founded on April 8, 1980, by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld, the company is headquartered in Thousand Oaks, CA. Notable Products and Research Areas Amgen, Inc. has developed several notable products, including: -Enbrel (etanercept), a treatment for rheumatoid arthritis and psoriatic arthritis - Neulasta (pegfilgrastim), a medication for preventing chemotherapy-induced neutropenia - Prolia (denosumab), a treatment for osteoporosis The company also conducts research in various areas, including: -Cancer treatment and therapy -Cardiovascular disease -Neurology and neuroscience -Inflammation and immunology
NASDAQ:AMGNLong
by ImmaculateTony
Long? Yes I Am-genNothing revolutionary here today, just an algo call on a stock that has been a solid performer for me historically. The rationale: --In a trading range longer term, but a short/medium term uptrend --right at short term support level --1313-1* W/L record with my algo (the 1 being 2 days ago and still would be open) --Avg. gain per trade is just over 2% ---Avg daily return is about 2.5x that of stocks in general, long term Initial entry was at 305.70. Per my usual strategy, I'll add to my position at the close on any day it still rates as a “buy” and I will use FPC (first profitable close) to exit any lot on the day it closes at any profit. As always - this is intended as "edutainment" and my perspective on what I am or would be doing, not a recommendation for you to buy or sell. Act accordingly and invest at your own risk. DYOR and only make investments that make good financial sense for you in your current situation.
NASDAQ:AMGNLong
by redwingcoach
1
AMGEN Nearing a Breakout—Is It Time to Act?Is AMGN on the Verge of a Major Move? With Amgen Inc. (NASDAQ: AMGN) currently trading at $287.38, the stock is hovering close to key resistance at $294.65, a level that could dictate its next big move. Despite sitting 17% below its historical high of $346.85, AMGN has rallied significantly from its absolute low of $211.71, reflecting a 35% rebound. Technical indicators suggest the stock is approaching a crucial inflection point. The RSI14 at 59.99 shows the stock is nearing overbought conditions but hasn't crossed the threshold yet, while the MFI at 64.63 hints at strong money flow. Moving averages are aligned bullishly, with MA50 at $283.00, MA100 at $279.02, and MA200 at $272.19, all supporting the uptrend. However, recent "Sell Volumes Take Over" patterns indicate increased selling pressure near highs, creating potential short-term volatility. Will buyers absorb the selling and push AMGN through resistance, or is the stock setting up for a reversal? With macroeconomic uncertainty and biotech sector sentiment playing a role, this could be a make-or-break moment for AMGN traders and investors. The big question—are you positioned for what’s next? AMGN Price Roadmap: Decoding Market Moves Step by Step Tracking AMGN’s price action through pattern recognition gives traders an edge in predicting potential moves. Let’s break down the most relevant patterns that played out successfully, confirming their main direction. 1. January 27, 2025 - Buy Volumes Take Over (Sell Direction Ignored) Price opened and closed at $282, but despite a 6.35% range, the bearish move wasn't confirmed. Instead, we saw an influx of Buy Volumes Max just hours later, setting the stage for an upward move. 2. January 28, 2025 - Increased Buy Volumes (Confirmed Uptrend) The Buy Volumes Max pattern held strong, with price climbing to a high of $283.22 before consolidating. This confirmed that the previous sell pattern failed, while buyers took control. 3. January 31, 2025 - Sell Volumes Take Over (Bearish Shift Confirmed) Price action showed heavy selling pressure, with a range of $285.42 - $287.11. The next pattern, Increased Sell Volumes, validated the bearish momentum, confirming a 4.71% decline shortly after. 4. February 1, 2025 - Increased Sell Volumes (Downtrend Holds) The continuation of high sell volumes pushed AMGN down to $284.92, confirming a successful transition from the previous Sell Volumes Takeover pattern. Traders caught in longs at resistance likely got shaken out, while aggressive sellers dominated the flow. What’s Next? With AMGN testing key resistance near $287, the next pattern will be crucial. A break above resistance could invalidate the current bearish structure, while a failure to hold recent highs could send price back toward the $280 zone. Watch the order flow carefully—the next move could be explosive. Technical & Price Action Analysis: Key Levels to Watch In trading, levels are everything. If a support doesn’t hold, it flips into resistance—same story in reverse. Here’s what we’re watching right now on AMGN: Support Levels to Catch a Bid 259.29 – First real demand zone; buyers need to step in here. 252.45 – If this level doesn’t hold, expect liquidity grabs below. 251.47 – Close to the danger zone, where panic selling could accelerate. 248.56 – Bulls’ last line of defense before a major flush. 231.50 – If we see this, something bigger is at play. Resistance Levels That Must Break for Upside 294.65 – First stop for any real breakout traders. 300.00 – Psychological round number, algos are watching. 318.54 – Mid-term target if we get momentum. 328.35 – A key pivot for long-term positioning. 330.92 – Break above here, and we’re in new territory. Power Levels – Where Big Money Is Positioned Support that Must Hold: 297.91 – If lost, could act as strong resistance on retest. 325.91 – Major liquidity zone, failure here signals deep correction. 333.15 – Last line before heavy trend Trading Strategies Based on Rays: Key Scenarios & Setups The VSA Rays mapped on the chart serve as the foundation for our trading framework. These Fibonacci-based dynamic levels define zones of interaction, where price has two choices—continue the trend or reverse. Positions should only be considered after price interaction with the rays and the confirmation of a directional move. Each price move progresses from ray to ray, establishing first, second, and third targets for trades. Moving Averages further refine these levels, acting as dynamic support and resistance zones. 📈 Optimistic Scenario: Trend Continuation & Breakout Play If price successfully interacts with the MA50 ($283.00) and MA100 ($279.02) and bounces off a VSA ray, we are looking at a bullish continuation. First target: $294.65 (Initial breakout zone) Second target: $300.00 (Psychological and technical resistance) Third target: $318.54 (Longer-term target for swing traders) Key trigger: Confirmation above the breakout ray + moving average support. A strong close above these levels increases the probability of a trend continuation. 📉 Pessimistic Scenario: Rejection & Breakdown Play If price interacts with $294.65 but fails to break through, then a reversal setup is in play. First target: $259.29 (Initial support zone) Second target: $252.45 (Key demand level) Third target: $231.50 (Bearish exhaustion zone) Key trigger: Rejection at resistance ray + moving average failure. If price fails to hold MA50 ($283.00) or MA100 ($279.02), it signals a deeper correction. 🔥 Trade Setups Based on Key Levels Breakout Buy above $294.65 → Target $300.00, $318.54 Reversal Short from $294.65 → Target $283.00, $259.29 Bounce Buy from $259.29 → Target $294.65, $300.00 Sell on Breakdown below $259.29 → Target $252.45, $231.50 Resistance That Could Reject Hard: 244.25 – Hidden selling pressure waiting above. 227.79 – Institutional sell wall if price wicks up. If these support levels get sliced through, expect them to flip into resistance, trapping weak hands and fueling the next move. Keep stops tight—this game isn’t for the faint-hearted. 🚀 Let’s Talk Trading – Drop Your Comments Below! Markets move, but precision matters—and that’s why you should save this idea and check back later to see how price respects my levels. If you find these insights useful, hit that Boost button and let’s keep tracking the moves together! 📈 Got questions? Want to discuss a setup? Drop them in the comments—I always check and answer! And if you have a specific asset you’d like analyzed, let me know. Some ideas I can share publicly, while others we can keep private, depending on what you need. My ray-based strategy maps out all key levels automatically, but it’s only available in Private. If you’re interested in using it, just send me a DM. Trust me, once you see how price follows the rays, you’ll never trade the same way again. The best part? These levels work on any asset. If you want a custom markup—just say the word. Let me know which tickers you’re watching, and I’ll add them to my list for upcoming analyses. More Boosts = more priority! And of course, if you’re new here, follow me on TradingView to stay updated on fresh ideas. Smart trading is all about being in the right place at the right time. Let’s catch these moves together! 🚀🔥
NASDAQ:AMGNLong
by brandlabelden
$AMGN observationThis is just my observation, not advice. Technical: 1. Price touched the 200 SMA. 2. Price is corrected to 50% correction and slightly pumped after reaching the supportive zone. 3. Price reached the volume price of FRVP around 270$. 4. The correction nature of the latest candles in the blue box is obvious. 5. In the daily and 4H charts, the stock is almost in the oversold zone. 6. A significant divergence is observable on the daily chart. Fundamental: 1. P/E ratio: 34.4x (Not undervalued) 2. In November 2024, Amgen's Phase 2 study of MariTide showed a 20% average weight loss over 52 weeks in obese patients without diabetes. While promising, it fell short of analysts' 23–25% expectations, raising concerns about its competitiveness against treatments like Eli Lilly's Zepbound and Novo Nordisk's Wegovy. 3. On November 26th, after MariTide phase 2 announcement, the price was mixed but could be considered to have moved up impulsively. 4. On 5th December, Amgen announced to invest 1B for expansion. 5. NASDAQ:AMGN launched Pavblu as a rival of NASDAQ:REGN 's Eylea. 6. On December 7th, NASDAQ:AMGN out significant result for Blinatumomab. 7. Based on reports, NASDAQ:AMGN raises quarterly dividend 5.8%. 8. Analyst sentiments: 14 buy, 15 hold, 3 sell. Scenarios: We are in the correction with two main scenarios: 1. ABC correction has been completed and impulsive waves have been started so we should look for entry. 2. A correction wave has been completed, and we are now in the B wave correction. In this case, we should see another price drop on wave C. After then, we can look for long on around 78% correction and trendline.
NASDAQ:AMGNLong
by jack_the_real_trader